远程医疗对肥胖非酒精性脂肪肝患者效果的系统综述与Meta分析数据表

数据集获取（Figshare）

• 源站标题：Data_Sheet_1_Effects of Telemedicine on Obese Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.pdf
• DOI：10.3389/fmed.2021.723790.s001
• 发布日期：2021-08-19
• 文件数：1 个
• 文件总体积：140.23 KB
• 源站页面：https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Effects_of_Telemedicine_on_Obese_Patients_With_Non-alcoholic_Fatty_Liver_Disease_A_Systematic_Review_and_Meta-Analysis_pdf/15258957

命令行下载

curl -L -o "Data_Sheet_1_Effects of Telemedicine on Obese Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.pdf" "https://ndownloader.figshare.com/files/29240148"

文件清单

• Data_Sheet_1_Effects of Telemedicine on Obese Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.pdf（140.23 KB）

文件总体积 140.23 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Background: Little is known of the efficacy of telemedicine on the clinical outcomes of the high-risk group of non-alcoholic fatty liver disease (NAFLD) patients, such as those with obesity. This study aimed to determine the effects of telemedicine vs. usual care for the management of obese patients with NAFLD.
Methods: Literature searches were performed from inception to 1st June 2021 in the following databases: Cochrane CENTRAL, ScienceDirect, PubMed, and Scopus. Prospective trials assessed the effects of telemedicine on obese patients with NAFLD were included. The outcomes of interest were alanine aminotransferase (ALT), aspartate aminotransferase (AST), triglyceride, high-density lipoprotein cholesterol levels, and body mass index, which were reported as weighted mean difference (WMD) with 95% confidence interval (CI).
Results: Four studies were examined in the systematic review, one was excluded from the meta-analysis due to an inappropriate group-comparison. In all, 285 obese patients with NAFLD were included in the meta-analysis (70% of those received telemedicine intervention). The mean ages of the patients in the telemedicine and usual-care groups were 51.78 ± 5.91 and 47.30 ± 8.14 years, respectively. Telemedicine significantly decreased ALT levels compared with usual care (WMD = −18.93 U/L [95%CI: −25.97, −11.90]; I2 = 53.8%), and it significantly decreased AST levels (WMD = −10.24 U/L [95%CI: −13.43, −7.05]; I2 = 0.0%). However, telemedicine did not show significant benefits for the remaining outcomes.
Conclusion: Compared with usual care, telemedicine significantly reduced the AST and ALT levels of obese patients with NAFLD. Further long-term studies with clinical endpoints are needed to determine the best characteristics of telemedicine and to confirm the benefits.
Systematic Review Registration: PROSPERO [CRD42020207451].

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fmed.2021.723790.s001（source: https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Effects_of_Telemedicine_on_Obese_Patients_With_Non-alcoholic_Fatty_Liver_Disease_A_Systematic_Review_and_Meta-Analysis_pdf/15258957）。